Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 17, 2024 - Issue
Submit an article Journal homepage
46
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD

Houxi Xu1 Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China;2 School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, NanjingPeople’s Republic of ChinaView further author information
,
Hongqun Zhang1 Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China;3 The Third School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of ChinaView further author information
,
Songxian Sun2 School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, NanjingPeople’s Republic of ChinaView further author information
,
Jingyuan Zhang2 School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, NanjingPeople’s Republic of ChinaView further author information
,
Jiege Huo1 Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China;3 The Third School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0463-134XView further author information
ORCID Icon &
Chunxiang Zhou2 School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, NanjingPeople’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 133-148 | Received 18 Dec 2023, Accepted 04 Apr 2024, Published online: 16 Apr 2024

References

  • Baidoun F, Elshiwy K, Elkeraie Y, et al. Colorectal Cancer Epidemiology: recent Trends and Impact on Outcomes. Curr Drug Targets. 2021;22(9):998–1009. doi:10.2174/18735592MTEx9NTk2y
  • Sung H, Ferlay J, Siegel RL, et al. Global CANCER STATISTIcs 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233–254.
  • Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584–590.
  • Benson AB, Venook AP, Al-Hawary MM, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329–359.
  • Lee MS, Menter DG, Kopetz S. Right versus left colon cancer biology: integrating the consensus molecular subtypes. J Natl Compr Canc Netw. 2017;15(3):411–419.
  • Evans DA. N-acetyltransferase. Pharmacol Ther. 1989;42(2):157–234.
  • Windmill KF, Gaedigk A, Hall PM, Samaratunga H, Grant DM, McManus ME. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol Sci. 2000;54(1):19–29.
  • Sharma S, Cao X, Wilkens LR, et al. Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2010;19(7):1866–1870.
  • Hernandez-Gonzalez O, Herrera-Vargas DJ, Martinez-Leija ME, Zavala-Reyes D, Portales-Perez DP. The role of arylamine N-acetyltransferases in chronic degenerative diseases: their possible function in the immune system. Biochim Biophys Acta Mol Cell Res. 2022;1869(9):119297. doi:10.1016/j.bbamcr.2022.119297
  • Johansson I, Nilsson C, Berglund P, et al. Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker. Breast Cancer Res. 2012;14(1):R31. doi:10.1186/bcr3116
  • Dhaini HR, El Hafi B, Khamis AM. NAT1 genotypic and phenotypic contribution to urinary bladder cancer risk: a systematic review and meta-analysis. Drug Metab Rev. 2018;50(2):208–219. doi:10.1080/03602532.2017.1415928
  • Gong C, Hu X, Gao Y, Cao Y, Gao F, Mo Z. A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review. Med Oncol. 2011;28(1):365–376. doi:10.1007/s12032-010-9423-5
  • Endo Y, Yamashita H, Takahashi S, et al. Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer. BMC Cancer. 2014;14(1):990. doi:10.1186/1471-2407-14-990
  • Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000;9(1):29–42.
  • Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W1.
  • Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400–416 e411.
  • Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics. 2009;2(1):18. doi:10.1186/1755-8794-2-18
  • Hung JH, Yang TH, Hu Z, Weng Z, DeLisi C. Gene set enrichment analysis: performance evaluation and usage guidelines. Brief Bioinform. 2012;13(3):281–291. doi:10.1093/bib/bbr049
  • Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739–1740.
  • Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
  • Pedersen BS, Yang IV, De S. CruzDB: software for annotation of genomic intervals with UCSC genome-browser database. Bioinformatics. 2013;29(23):3003–3006. doi:10.1093/bioinformatics/btt534
  • Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141.
  • Sekiya S, Imamura K, Takeuchi S, et al. Pathological complete response of locally advanced colon cancer after preoperative radiotherapy: a case report and narrative review of the literature. Surg Case Rep. 2018;4(1):58.
  • Mathis KL, Nelson H. Controversies in laparoscopy for colon and rectal cancer. Surg Oncol Clin N Am. 2014;23(1):35–47.
  • Zheng CX, Zhan WH, Zhao JZ, et al. The prognostic value of preoperative serum levels of CEA, CA19-9 and CA72-4 in patients with colorectal cancer. World J Gastroenterol. 2001;7(3):431–434.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.